Omeros reported $-39494000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acelrx Pharmaceuticals ACRX:US $ -8.67M 0.76M
Adma Biologics ADMA:US $ -18.34M 1.69M
Alnylam Pharmaceuticals ALNY:US $ -239.36M 20.95M
Biomarin Pharmaceutical BMRN:US $ 26.19M 92.76M
Cytokinetics CYTK:US $ -86.75M 56.18M
Dynavax Technologies DVAX:US $ 32.86M 67.73M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Insmed INSM:US $ -94236000 18.78M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Macrogenics MGNX:US $ -66.44M 8.42M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Omeros OMER:US $ -39494000 7.82M
Pacira Pharmaceuticals PCRX:US $ 39.79M 19.7M
Pfizer PFE:US $ 11328M 4083M
Regulus Therapeutics RGLS:US $ -6.72M 0.42M
Sangamo Biosciences SGMO:US $ -43.92M 6.36M
Sarepta Therapeutics SRPT:US $ -104.15M 17.74M
United Therapeutics UTHR:US $ 308.7M 168.2M
Vital Therapies VTL:US $ -20.81M 0.38M
Xoma XOMA:US $ -2.28M 32.22M